Goldman Sachs downgrades Valneva stock rating to sell on Lyme vaccine uncertainty



[
Goldman Sachs downgrades Valneva stock rating to sell on Lyme vaccine uncertainty
[og_img]
https://www.investing.com/news/analyst-ratings/goldman-sachs-downgrades-valneva-stock-rating-to-sell-on-lyme-vaccine-uncertainty-93CH-4628062


Investing.com

Latest articles

spot_imgspot_img

Related articles

Leave a reply

Please enter your comment!
Please enter your name here

spot_imgspot_img